2,288
Views
76
CrossRef citations to date
0
Altmetric
Research Paper

The role of Rac1 in the regulation of NF-kB activity, cell proliferation, and cell migration in non-small cell lung carcinoma

, , , , &
Pages 647-656 | Received 04 Nov 2011, Accepted 20 Mar 2012, Published online: 01 Jun 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Haojun Shi, Shufeng Li, Yun Geng, Huancai Fan, Ruojia Zhang, Yuang Zhang, Jihong Pan, Guanhua Song, Luna Ge, Tianhua Xie & Lin Wang. (2022) Euphorbia factor L3 ameliorates rheumatoid arthritis by suppressing the inflammatory response by targeting Rac family small GTPase 1. Bioengineered 13:4, pages 10985-10998.
Read now
Bin Liu, Wei Cao & Hui Ma. (2019) Knockdown of lncRNA LSINCT5 suppresses growth and metastasis of human glioma cells via up-regulating miR-451. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 2507-2515.
Read now
Sergej Skvortsov, Paul Debbage & Ira Skvortsova. (2014) Proteomics of cancer stem cells. International Journal of Radiation Biology 90:8, pages 653-658.
Read now
Sergej Skvortsov, Paul Debbage, William CS Cho, Peter Lukas & Ira Skvortsova. (2014) Putative biomarkers and therapeutic targets associated with radiation resistance. Expert Review of Proteomics 11:2, pages 207-214.
Read now
Nathan Schuld, Andrew Hauser, Adam Gastonguay, Jessica Wilson, Ellen Lorimer & Carol Williams. (2014) SmgGDS-558 regulates the cell cycle in pancreatic, non-small cell lung, and breast cancers. Cell Cycle 13:6, pages 941-952.
Read now

Articles from other publishers (71)

Masae Yamazaki, Shoichi Sekikawa, Taiki Suzuki, Satoru Ogane, Kazuhiko Hashimoto, Aya Sasaki & Takeshi Nomura. (2023) Rac1 activation in oral squamous cell carcinoma as a predictive factor associated with lymph node metastasis. International Journal of Clinical Oncology.
Crossref
Olivia J. Koehn, Ellen Lorimer, Bethany Unger, Ra’Mal Harris, Akansha S. Das, Kiall F. Suazo, Shelby A. Auger, Mark D. Distefano, Jeremy W. Prokop & Carol L. Williams. (2023) GTPase splice variants RAC1 and RAC1B display isoform-specific differences in localization, prenylation, and interaction with the chaperone protein SmgGDS. Journal of Biological Chemistry 299:6, pages 104698.
Crossref
Yingying Wang, Minli Wei, Min Su, Zhiyuan Du, Jiaxi Dong, Yu Zhang, Yingdi Wu, Xiaopeng Li, Ling Su & Xiangguo Liu. (2023) DIRAS3 enhances RNF19B-mediated RAC1 ubiquitination and degradation in non-small cell lung cancer cells. iScience, pages 107157.
Crossref
You Ri Park, Min Jung Kong, Mi Ra Noh & Kwon Moo Park. (2023) Rac1 inhibition protects the kidney against kidney ischemia/reperfusion through the inhibition of macrophage migration. The Korean Journal of Physiology & Pharmacology 27:3, pages 257-265.
Crossref
Michael J Lukey, Yijian Qiu, Wen-Hsuan Yang & Richard A Cerione. 2023. Encyclopedia of Cell Biology. Encyclopedia of Cell Biology 260 271 .
Stefania Tocci, Stella-Rita Ibeawuchi, Soumita Das & Ibrahim M. Sayed. (2022) Role of ELMO1 in inflammation and cancer—clinical implications. Cellular Oncology 45:4, pages 505-525.
Crossref
Xiaoyu Ji, Xiaoping Chen, Bixiang Zhang, Meng Xie, Tongyue Zhang, Xiangyuan Luo, Danfei Liu, Yangyang Feng, Yijun Wang, Mengyu Sun, Congxin Li, Wenjie Huang & Limin Xia. (2022) T-box transcription factor 19 promotes hepatocellular carcinoma metastasis through upregulating EGFR and RAC1. Oncogene 41:15, pages 2225-2238.
Crossref
Zhuohong Li, Juncai Tian, Lei Du, Ying Gao, Yao Wang, Fengming You & Li Wang. (2021) Anlotinib exerts anti‐cancer efficiency on lung cancer stem cells in vitro and in vivo through reducing NF‐κB activity. Journal of Cellular and Molecular Medicine 25:12, pages 5547-5559.
Crossref
Xishuang Wang, Zengtao Wei, Zhongyun Tang, Chenyue Xue, Huayun Yu, Derui Zhang, Yulan Li, Xihong Liu, Yongyu Shi, Lining Zhang, Guoling Chen, Huaiyu Zhou, Jianing Wang & Xiaoyan Wang. (2021) IL-37bΔ1-45 suppresses the migration and invasion of endometrial cancer cells by targeting the Rac1/NF-κB/MMP2 signal pathway. Laboratory Investigation 101:6, pages 760-774.
Crossref
Jiaxin Liang, Linda Oyang, Shan Rao, Yaqian Han, Xia Luo, Pin Yi, Jinguan Lin, Longzheng Xia, Jiaqi Hu, Shiming Tan, Lu Tang, Qing Pan, Yanyan Tang, Yujuan Zhou & Qianjin Liao. (2021) Rac1, A Potential Target for Tumor Therapy. Frontiers in Oncology 11.
Crossref
Ana Masara Ahmad Mokhtar, Ilie Fadzilah Hashim, Muaz Mohd Zaini Makhtar, Nor Hawani Salikin & Syafinaz Amin-Nordin. (2021) The Role of RhoH in TCR Signalling and Its Involvement in Diseases. Cells 10:4, pages 950.
Crossref
Matías S. Ciarlantini, Andrea Barquero, Juan Bayo, Diana Wetzler, Martín M. Dodes Traian, Hernán A. Bucci, Esteban J. Fiore, Lucía Gandolfi Donadío, Lucas Defelipe, Adrián Turjanski, Javier A. Ramírez, Guillermo Mazzolini & Maria J. Comin. (2021) Development of an Improved Guanidine‐Based Rac1 Inhibitor with in vivo Activity against Non‐Small Cell Lung Cancer. ChemMedChem 16:6, pages 1011-1021.
Crossref
Gerco den Hartog, Lindsay D. Butcher, Amber L. Ablack, Laura A. Pace, Jailal N. G. Ablack, Richard Xiong, Soumita Das, Thaddeus S. Stappenbeck, Lars Eckmann, Peter B. Ernst & Sheila E. Crowe. (2021) Apurinic/Apyrimidinic Endonuclease 1 Restricts the Internalization of Bacteria Into Human Intestinal Epithelial Cells Through the Inhibition of Rac1. Frontiers in Immunology 11.
Crossref
K. A. Pickering, K. Gilroy, J. W. Cassidy, S. K. Fey, A. K. Najumudeen, L. B. Zeiger, D. F. Vincent, D. M. Gay, J. Johansson, R. P. Fordham, B. Miller, W. Clark, A. Hedley, E. B. Unal, C. Kiel, E. McGhee, L. M. Machesky, C. Nixon, A. E. Johnsson, M. Bain, D. Strathdee, S. R. van Hoof, J. P. Medema, K. I. Anderson, S. M. Brachmann, V. M. Stucke, A. Malliri, M. Drysdale, M. Turner, L. Serrano, K. Myant, A. D. Campbell & O. J. Sansom. (2021) A RAC-GEF network critical for early intestinal tumourigenesis. Nature Communications 12:1.
Crossref
Erma Yunita, Haruma Anggraini Muflikhasari, Gagas Pradani Nur Ilmawati, Edy Meiyanto & Adam Hermawan. (2020) Hesperetin alleviates doxorubicin-induced migration in 4T1 breast cancer cells. Future Journal of Pharmaceutical Sciences 6:1.
Crossref
Huan Deng, Yichao Huang, Li Wang & Ming Chen. (2020) High Expression of UBB, RAC1, and ITGB1 Predicts Worse Prognosis among Nonsmoking Patients with Lung Adenocarcinoma through Bioinformatics Analysis. BioMed Research International 2020, pages 1-14.
Crossref
Salman Ahmed, Haroon Khan, Michael Aschner, Hamed Mirzae, Esra Küpeli Akkol & Raffaele Capasso. (2020) Anticancer Potential of Furanocoumarins: Mechanistic and Therapeutic Aspects. International Journal of Molecular Sciences 21:16, pages 5622.
Crossref
Jing Xu, Nicola Galvanetto, Jihua Nie, Yili Yang & Vincent Torre. (2020) Rac1 Promotes Cell Motility by Controlling Cell Mechanics in Human Glioblastoma. Cancers 12:6, pages 1667.
Crossref
Pradip De, Brett James Rozeboom, Jennifer Carlson Aske & Nandini Dey. (2020) Active RAC1 Promotes Tumorigenic Phenotypes and Therapy Resistance in Solid Tumors. Cancers 12:6, pages 1541.
Crossref
Shaoming Guo, Ying Wang, Yimin Li, Yunjing Li, Changjiang Feng & Zhanghong Li. (2020) Daidzein-rich isoflavones aglycone inhibits lung cancer growth through inhibition of NF-κB signaling pathway. Immunology Letters 222, pages 67-72.
Crossref
Nam-Yi Kim, Young-Ah Suh, Soyoung Kim & ChuHee Lee. (2020) Bufalin down-regulates Axl expression to inhibit cell proliferation and induce apoptosis in non-small-cell lung cancer cells. Bioscience Reports 40:4.
Crossref
Chun-Wen Zheng, Rui-Jie Zeng, Li-Yan Xu & En-Min Li. (2020) Rho GTPases: Promising candidates for overcoming chemotherapeutic resistance. Cancer Letters 475, pages 65-78.
Crossref
Julia R. Seiz, Johannes Klinke, Laura Scharlibbe, Dirk Lohfink, Marisa Heipel, Hendrik Ungefroren, Klaudia Giehl & Andre Menke. (2020) Different signaling and functionality of Rac1 and Rac1b in the progression of lung adenocarcinoma. Biological Chemistry 401:4, pages 517-531.
Crossref
Honghai Dai, Yang W. Shao, Xiaoling Tong, Xue Wu, Jiaohui Pang, Alei Feng & Zhe Yang. (2019) YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma . Cancer Medicine 9:5, pages 1628-1637.
Crossref
Mariana Cooke, Martin J. Baker & Marcelo G. Kazanietz. (2020) Rac-GEF/Rac Signaling and Metastatic Dissemination in Lung Cancer. Frontiers in Cell and Developmental Biology 8.
Crossref
Alessandro Rossi, Michela Roberto, Martina Panebianco, Andrea Botticelli, Federica Mazzuca & Paolo Marchetti. (2019) Drug resistance of BRAF-mutant melanoma: Review of up-to-date mechanisms of action and promising targeted agents. European Journal of Pharmacology 862, pages 172621.
Crossref
Rui‐Jie Zeng, Chun‐Wen Zheng, Jing‐E Gu, Hai‐Xia Zhang, Lei Xie, Li‐Yan Xu & En‐Min Li. (2019) RAC1 inhibition reverses cisplatin resistance in esophageal squamous cell carcinoma and induces downregulation of glycolytic enzymes. Molecular Oncology 13:9, pages 2010-2030.
Crossref
Inga Peciuliene, Laurynas Vilys, Egle Jakubauskiene, Lolita Zaliauskiene & Arvydas Kanopka. (2019) Hypoxia alters splicing of the cancer associated Fas gene. Experimental Cell Research 380:1, pages 29-35.
Crossref
Erik T. Goka, Pallavi Chaturvedi, Dayrelis T. Mesa Lopez, Adriana De La Garza & Marc E. Lippman. (2019) RAC1b Overexpression Confers Resistance to Chemotherapy Treatment in Colorectal Cancer. Molecular Cancer Therapeutics 18:5, pages 957-968.
Crossref
Frank Aboubakar Nana, Marylène Lecocq, Maha Zohra Ladjemi, Bruno Detry, Sébastien Dupasquier, Olivier Feron, Pierre P. Massion, Yves Sibille, Charles Pilette & Sebahat Ocak. (2019) Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell Lung Cancer. Molecular Cancer Therapeutics 18:1, pages 17-27.
Crossref
Björn L.D.M. Brücher & Ijaz S. Jamall. (2019) Transition from normal to cancerous cell by precancerous niche (PCN) induced chronic cell-matrix stress. 4open 2, pages 14.
Crossref
Stephanie Pohlmann, Stefanie Scheu, Verena Ziegler, Nicole Schupp, Christian Henninger & Gerhard Fritz. (2018) Hepatic Rac1 GTPase contributes to liver-mediated basal immune homeostasis and LPS-induced endotoxemia. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1865:9, pages 1277-1292.
Crossref
Feng Liu, Hongjuan Hu, Jianfu Zhao, Zhiwei Zhang, Xiaohong Ai, Liyun Tang & Liming Xie. (2018) miR‑124‑3p acts as a potential marker and suppresses tumor growth in gastric cancer. Biomedical Reports.
Crossref
Fanfan Xu, Xinghua Qiu, Xinyan Hu, Yu Shang, Michal Pardo, Yanhua Fang, Junxia Wang, Yinon Rudich & Tong Zhu. (2018) Effects on IL-1β signaling activation induced by water and organic extracts of fine particulate matter (PM2.5) in vitro. Environmental Pollution 237, pages 592-600.
Crossref
Kiyoshi Takagi, Yasuhiro Miki, Yoshiaki Onodera, Takanori Ishida, Mika Watanabe, Hironobu Sasano & Takashi Suzuki. (2018) ARHGAP15 in Human Breast Carcinoma: A Potent Tumor Suppressor Regulated by Androgens. International Journal of Molecular Sciences 19:3, pages 804.
Crossref
You‑Sheng Huang, Na Jie, Yi‑Xin Zhang, Ke‑Jian Zou & Yang Weng. (2017) shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1. International Journal of Molecular Medicine.
Crossref
Yuichi Mazaki, Yasuhito Onodera, Tsunehito Higashi, Takahiro Horinouchi, Tsukasa Oikawa & Hisataka Sabe. (2017) ARF1 recruits RAC1 to leading edge in neutrophil chemotaxis. Cell Communication and Signaling 15:1.
Crossref
Maia Cabrera, Emiliana Echeverria, Federico Remes Lenicov, Georgina Cardama, Nazareno Gonzalez, Carlos Davio, Natalia Fernández & Pablo Lorenzano Menna. (2017) Pharmacological Rac1 inhibitors with selective apoptotic activity in human acute leukemic cell lines. Oncotarget 8:58, pages 98509-98523.
Crossref
Michael Crompton, Tom Purnell, Hayley E. Tyrer, Andrew Parker, Greg Ball, Rachel E. Hardisty-Hughes, Richard Gale, Debbie Williams, Charlotte H. Dean, Michelle M. Simon, Ann-Marie Mallon, Sara Wells, Mahmood F. Bhutta, Martin J. Burton, Hilda Tateossian & Steve D. M. Brown. (2017) A mutation in Nischarin causes otitis media via LIMK1 and NF-κB pathways. PLOS Genetics 13:8, pages e1006969.
Crossref
Vasiliki Galani, Michalis Kastamoulas, Anna Varouktsi, Evangeli Lampri, Antigoni Mitselou & Dimitrios L. Arvanitis. (2016) IFNs-signaling effects on lung cancer: an up-to-date pathways-specific review. Clinical and Experimental Medicine 17:3, pages 281-289.
Crossref
Mi Jeong Kim, Won Sam Kim, Dong Oh Kim, Jae-Eun Byun, Hangsak Huy, Soo Yun Lee, Hae Young Song, Young-Jun Park, Tae-Don Kim, Suk Ran Yoon, Eun-Ji Choi, Hyunjung Ha, Haiyoung Jung & Inpyo Choi. (2017) Macrophage migration inhibitory factor interacts with thioredoxin-interacting protein and induces NF-κB activity. Cellular Signalling 34, pages 110-120.
Crossref
Benjaporn Buranrat, Nootchanat Mairuae & Ampa Konsue. (2017) Cratoxy formosum leaf extract inhibits proliferation and migration of human breast cancer MCF-7 cells. Biomedicine & Pharmacotherapy 90, pages 77-84.
Crossref
T. Zou, X. Mao, J. Yin, X. Li, J. Chen, T. Zhu, Q. Li, H. Zhou & Z. Liu. (2017) Emerging roles of RAC1 in treating lung cancer patients . Clinical Genetics 91:4, pages 520-528.
Crossref
Teresa Amaral, Tobias Sinnberg, Friedegund Meier, Clemens Krepler, Mitchell Levesque, Heike Niessner & Claus Garbe. (2017) The mitogen-activated protein kinase pathway in melanoma part I – Activation and primary resistance mechanisms to BRAF inhibition. European Journal of Cancer 73, pages 85-92.
Crossref
Zhang Zhang, Wei Rui, Zi-Chen Wang, Da-Xin Liu & Lin Du. (2017) Anti-proliferation and anti-metastasis effect of barbaloin in non-small cell lung cancer via inactivating p38MAPK/Cdc25B/Hsp27 pathway. Oncology Reports 38:2, pages 1172-1180.
Crossref
Youn Ju Lee, Taeho Lim, Min Su Han, Sun-Hwa Lee, Suk-Hwan Baek, Hong-Yan Nan & Chuhee Lee. (2017) Anticancer effect of luteolin is mediated by downregulation of TAM receptor tyrosine kinases, but not interleukin-8, in non-small cell lung cancer cells. Oncology Reports 37:2, pages 1219-1226.
Crossref
Zequn Li, Chun Guo, Xianglan Liu, Chengjun Zhou, Faliang Zhu, Xiaoyan Wang, Qun Wang, Yongyu Shi, Jianing Wang, Wei Zhao & Lining Zhang. (2016) TIPE2 suppresses angiogenesis and non-small cell lung cancer (NSCLC) invasiveness via inhibiting Rac1 activation and VEGF expression. Oncotarget 7:38, pages 62224-62239.
Crossref
Vishal Sahu, Abhishek Gupta, Rahul Kumar, Tarang Gupta, Anant Mohan & Sharmistha Dey. (2016) Quantification of Rac1 and Rac1b in serum of non small cell lung cancer by label free real time assay. Clinica Chimica Acta 460, pages 231-235.
Crossref
Linyuan Shen, Jingjing Du, Yudong Xia, Zhendong Tan, Yuhua Fu, Qiong Yang, Xuewei Li, Guoqing Tang, Yanzhi Jiang, Jinyong Wang, Mingzhou Li, Shunhua Zhang & Li Zhu. (2016) Genome-wide landscape of DNA methylomes and their relationship with mRNA and miRNA transcriptomes in oxidative and glycolytic skeletal muscles. Scientific Reports 6:1.
Crossref
Alexandra O. Luby, Emily K. Breitner & Kristen K. Comfort. (2015) Preliminary protein corona formation stabilizes gold nanoparticles and improves deposition efficiency. Applied Nanoscience 6:6, pages 827-836.
Crossref
Carmen Bergom, Andrew D. Hauser, Amy Rymaszewski, Patrick Gonyo, Jeremy W. Prokop, Benjamin C. Jennings, Alexis J. Lawton, Anne Frei, Ellen L. Lorimer, Irene Aguilera-Barrantes, Alexander C. Mackinnon, Kathleen Noon, Carol A. Fierke & Carol L. Williams. (2016) The Tumor-suppressive Small GTPase DiRas1 Binds the Noncanonical Guanine Nucleotide Exchange Factor SmgGDS and Antagonizes SmgGDS Interactions with Oncogenic Small GTPases. Journal of Biological Chemistry 291:12, pages 6534-6545.
Crossref
Yani Liu, Jiali Zhou, Xiaomei Luo, Chunxiao Yang, Yu Zhang & Shaojun Shi. (2016) Association of RAC1 Gene Polymorphisms with Primary End-Stage Renal Disease in Chinese Renal Recipients. PLOS ONE 11:2, pages e0148270.
Crossref
M.J. Lukey & R.A. Cerione. 2016. Encyclopedia of Cell Biology. Encyclopedia of Cell Biology 731 740 .
Mazvita Maziveyi & Suresh K. Alahari. (2015) Breast Cancer Tumor Suppressors: A Special Emphasis on Novel Protein Nischarin. Cancer Research 75:20, pages 4252-4259.
Crossref
Vianey Gonzalez-Villasana, Enrique Fuentes-Mattei, Cristina Ivan, Heather J. Dalton, Cristian Rodriguez-Aguayo, Ricardo J. Fernandez-de Thomas, Burcu Aslan, Paloma del C. Monroig, Guermarie Velazquez-Torres, Rebecca A. Previs, Sunila Pradeep, Nermin Kahraman, Huamin Wang, Pinar Kanlikilicer, Bulent Ozpolat, George Calin, Anil K. Sood & Gabriel Lopez-Berestein. (2015) Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer. Clinical Cancer Research 21:9, pages 2127-2137.
Crossref
Sara Zanini, Francesco Giovinazzo, Daniele Alaimo, Ben Lawrence, Roswitha Pfragner, Claudio Bassi, Irvin Modlin & Mark Kidd. (2015) GNA15 expression in small intestinal neuroendocrine neoplasia: Functional and signalling pathway analyses. Cellular Signalling 27:5, pages 899-907.
Crossref
Sergej Skvortsov, Paul Debbage, Peter Lukas & Ira Skvortsova. (2015) Crosstalk between DNA repair and cancer stem cell (CSC) associated intracellular pathways. Seminars in Cancer Biology 31, pages 36-42.
Crossref
Xiaoliang Wu, Xuewen Liu, Sanjay Koul, Chang Youl Lee, Zhenfeng Zhang & Balazs Halmos. (2014) AXL kinase as a novel target for cancer therapy. Oncotarget 5:20, pages 9546-9563.
Crossref
Linette Castillo-Pichardo, Tessa Humphries-Bickley, Columba De La Parra, Ingrid Forestier-Roman, Magaly Martinez-Ferrer, Eliud Hernandez, Cornelis Vlaar, Yancy Ferrer-Acosta, Anthony V. Washington, Luis A. Cubano, Jose Rodriguez-Orengo & Suranganie Dharmawardhane. (2014) The Rac Inhibitor EHop-016 Inhibits Mammary Tumor Growth and Metastasis in a Nude Mouse Model. Translational Oncology 7:5, pages 546-555.
Crossref
Naoki Kaneto, Satoru Yokoyama, Yoshihiro Hayakawa, Shinichiro Kato, Hiroaki Sakurai & Ikuo Saiki. (2014) RAC 1 inhibition as a therapeutic target for gefitinib‐resistant non‐small‐cell lung cancer . Cancer Science 105:7, pages 788-794.
Crossref
Goran Marinković, Jeffrey Kroon, Mark Hoogenboezem, Kees A. Hoeben, Matthijs S. Ruiter, Kondababu Kurakula, Iker Otermin Rubio, Mariska Vos, Carlie J. M. de Vries, Jaap D. van Buul & Vivian de Waard. (2014) Inhibition of GTPase Rac1 in Endothelium by 6-Mercaptopurine Results in Immunosuppression in Nonimmune Cells: New Target for an Old Drug. The Journal of Immunology 192:9, pages 4370-4378.
Crossref
S Skvortsov, J Dudás, P Eichberger, M Witsch-Baumgartner, J Loeffler-Ragg, C Pritz, V H Schartinger, H Maier, J Hall, P Debbage, H Riechelmann, P Lukas & I Skvortsova. (2014) Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC). British Journal of Cancer 110:11, pages 2677-2687.
Crossref
Natalija Lukic, Rémy Visentin, Myriam Delhaye, Jean-Louis Frossard, Pierre Lescuyer, Jean-Marc Dumonceau & Annarita Farina. (2014) An integrated approach for comparative proteomic analysis of human bile reveals overexpressed cancer-associated proteins in malignant biliary stenosis. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1844:5, pages 1026-1033.
Crossref
Andrew D. Hauser, Carmen Bergom, Nathan J. Schuld, Xiuxu Chen, Ellen L. Lorimer, Jian Huang, Alexander C. Mackinnon & Carol L. Williams. (2014) The SmgGDS Splice Variant SmgGDS-558 Is a Key Promoter of Tumor Growth and RhoA Signaling in Breast Cancer. Molecular Cancer Research 12:1, pages 130-142.
Crossref
Joanna L. MacKay, Anshum Sood & Sanjay Kumar. (2014) Three-dimensional patterning of multiple cell populations through orthogonal genetic control of cell motility. Soft Matter 10:14, pages 2372-2380.
Crossref
Gehan H. Abo El-Magd, Omnia Abd El-Fattah & Eman M. Saied. (2014) Immunohistochemical expression of nuclear factor kappa-B/p65 and cyclooxygenase-2 in non-small cell lung cancer patients: Prognostic value and impact on survival. Egyptian Journal of Chest Diseases and Tuberculosis 63:1, pages 193-200.
Crossref
Jhy-Shrian Huang, Chun-Yu Cho, Chih-Chen Hong, Ming-De Yan, Mao-Chih Hsieh, Jong-Ding Lay, Gi-Ming Lai, Ann-Lii Cheng & Shuang-En Chuang. (2013) Oxidative stress enhances Axl-mediated cell migration through an Akt1/Rac1-dependent mechanism. Free Radical Biology and Medicine 65, pages 1246-1256.
Crossref
Hemant K. Bid, Ryan D. Roberts, Parmeet K. Manchanda & Peter J. Houghton. (2013) RAC1: An Emerging Therapeutic Option for Targeting Cancer Angiogenesis and Metastasis. Molecular Cancer Therapeutics 12:10, pages 1925-1934.
Crossref
Ke Wu, Shiliu Tian, Hillary Zhou & Yong Wu. (2013) Statins protect human endothelial cells from TNF-induced inflammation via ERK5 activation. Biochemical Pharmacology 85:12, pages 1753-1760.
Crossref
Yanxia Wang, Min Ding, Sarika Chaudhari, Yanfeng Ding, Joseph Yuan, Dorota Stankowska, Shaoqing He, Raghu Krishnamoorthy, Joseph T. Cunningham & Rong Ma. (2013) Nuclear Factor κB Mediates Suppression of Canonical Transient Receptor Potential 6 Expression by Reactive Oxygen Species and Protein Kinase C in Kidney Cells. Journal of Biological Chemistry 288:18, pages 12852-12865.
Crossref
Suranganie Dharmawardhane, Eliud Hernandez & Cornelis Vlaar. 2013. Inhibitors of the Ras Superfamily G-proteins, Part A. Inhibitors of the Ras Superfamily G-proteins, Part A 117 146 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.